Detalhe da pesquisa
1.
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents.
Cancer Cell
; 1(4): 325-37, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12086848
2.
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
Cancer Cell
; 6(6): 611-23, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15607965
3.
Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.
J Immunother
; 30(1): 64-74, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17198084